Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin
about
Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populationsThe Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics StudyGenome-Wide Analysis in Brazilians Reveals Highly Differentiated Native American Genome RegionsGenetics and genomics in Brazil: a promising futureRelationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsAnalysis of Immunological, Viral, Genetic, and Environmental Factors That Might Be Associated with Decreased Susceptibility to HIV Infection in Serodiscordant Couples in Florianópolis, Southern Brazil.Characterization of the genetic variation present in CYP3A4 in three South African populations.Frequency of TNFA, INFG, and IL10 Gene Polymorphisms and Their Association with Malaria Vivax and Genomic Ancestry.Complexities of CYP2D6 gene analysis and interpretation.Pharmacogenomic implications of population admixture: Brazil as a model case.Pharmacogenetics of coumarin anticoagulants in Brazilians.Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.Functional polymorphisms of xenobiotics metabolizing enzymes-a research topic.Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?High prevalence of dengue antibodies and the arginine variant of the FcγRIIa polymorphism in asymptomatic individuals in a population of Minas Gerais State, Southeast Brazil.INFLUENCE OF PHARMACOGENETIC POLYMORPHISMS AND DEMOGRAPHIC VARIABLES ON METFORMIN PHARMACOKINETICS IN AN ADMIXED BRAZILIAN COHORT.Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.Genetic variation in key genes associated with statin therapy in the Azores Islands (Portugal) healthy population.Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
P2860
Q28545128-2BC0BC07-89A6-4511-8430-77C67F934428Q28553937-BEAC06A5-DB10-4F18-AB6F-7AC6632C70A4Q30274962-CFFF806A-DF33-4394-9449-8758B644AC8EQ33960779-9FD283A1-596A-4EC6-AD3B-14299FFEA24DQ34065305-297367E8-D205-47AF-8B27-A8AAEB8AA006Q36294816-19EB1CB2-ACD8-493C-A8E7-42ECB00CC45FQ36617170-83D24300-EEF3-4D9B-A540-348E0C532162Q37483372-369D093C-72B5-45CC-B00B-7617C4146ED7Q38154914-76C418DA-EEEE-45AB-B1A6-2F1EE9B34927Q38180220-CA25A11D-EE71-4464-9E38-4CD2EA604747Q38262829-37228998-1B0E-4F81-848E-D13314991B02Q38896041-D2F3BD60-59E8-4C4D-A6B1-EA25FE05F4D0Q39944445-4B10B3BC-E18A-4A65-B94B-21D9DDEAC8D5Q40492924-9E111A91-5B2B-4716-8E40-78DCAB0C653DQ43568427-95032189-08D9-468C-BEF1-46BDF533238BQ47566249-BFAD2C01-9D5A-4538-8996-C2A26601A067Q47574097-EFBFD3AE-BB35-4A17-B726-8D179C4AC37FQ48202910-BCED8349-8342-429B-8B0A-681644961587Q50945427-65D22DE3-F998-468A-82CB-1CC60A4B1911Q51016561-60712865-B82F-4019-8DA5-8AA4E261067EQ52801124-39D18BE9-68BA-4103-8909-3C03015D0160Q53776103-75A57AAE-6CE7-4ABE-B5C7-29BB6607CE91
P2860
Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@ast
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@en
type
label
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@ast
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@en
prefLabel
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@ast
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@en
P2860
P50
P356
P1476
Pharmacogenomic Diversity amon ...... Color, and Geographical Origin
@en
P2093
Guilherme Suarez-Kurtz
Sergio Danilo Juno Pena
P2860
P356
10.3389/FPHAR.2012.00191
P577
2012-11-06T00:00:00Z